Open AccessExacerbation of atrial fibrillation related to dulaglutide use
Author(s) -
Lee Jayden,
Umana Idopise E.,
Nguyen Judy
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4223
Subject(s) - medicine , atrial fibrillation , cardiology , dulaglutide , exacerbation , pr interval , heart rate , blood pressure , liraglutide , type 2 diabetes , diabetes mellitus , endocrinology
Abstract Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre‐existing arrhythmia.